After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Olema Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Olema Pharmaceuticals Inc is $2.18B. A total of 1.49 million shares were traded on the day, compared to an average of 3.76M shares.
In the most recent transaction, CLARK IAN T sold 264,800 shares of OLMA for 29.73 per share on Dec 19 ’25. After the transaction, the Director now owns 0 company shares. In a previous transaction on Dec 19 ’25, Myles David C. sold 51,000 shares at 30.46 per share. OLMA shares that CH. DISCOV. & NON-CLIN DEV OFF owns now total 551,881.
Among the insiders who sold shares, Zojwalla Naseem disposed of 100,000 shares on Dec 22 ’25 at a per-share price of $28.04. This resulted in the Chief Medical Officer holding 53,997 shares of OLMA after the transaction. In another insider transaction, Zojwalla Naseem sold 99,509 shares at $27.66 per share on Dec 23 ’25. Company shares held by the Chief Medical Officer now total 4,488.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, OLMA has a high of $36.26 and a low of $2.86.
As of this writing, OLMA has an earnings estimate of -$0.53 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.47 per share and a lower estimate of -$0.65. The company reported an EPS of -$0.51 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. OLMA’s latest balance sheet shows that the firm has $287.25M in Cash & Short Term Investments as of fiscal 2021. There were $3.29M in debt and $9.02M in liabilities at the time. Its Book Value Per Share was $4.48, while its Total Shareholder’s Equity was $284.57M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for OLMA is Buy with a score of 4.80.
